Natalie McNamee

Natalie McNamee

Privat kapitalinvesterare på
Tarnagulla Ventures Pty Ltd.
Consumer Services
Health Technology
Finance

Profil

Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015.
She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis.
Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters.
She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer.
Quanticel was acquired by Celgene for $485M in 2015.
Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.

Aktiva positioner av Natalie McNamee

FöretagPositionStart
Privat kapitalinvesterare 2015-01-01

Tidigare kända positioner av Natalie McNamee

Natalie McNamees utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

1

Första gradens relationer

4

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag4

Consumer Services

Consumer Services

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Natalie McNamee